Ramkumar Iyer

Years Active: 2017-2023
Publications (10 Years): 5

Entasis Therapeutics

University of Houston (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Entasis Therapeutics Jul 01 2015

United States

Principal Scientist (Bacteriology) :: Biology

Vertex Pharmaceuticals Inc Nov 19 2007 - May 31 2015

United States

Research Scientist II :: Infectious diseases

Education History

University of Houston

United States

PHD :: Biology and Biochemistry

Publications

Samir H Moussa, Adam B Shapiro, Sarah M McLeod, Ramkumar Iyer, Nicole M Carter, Yu-Kuo Tsai, L Kristopher Siu, Alita A Miller
Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii . Antimicrobial agents and chemotherapy (2023)
Ramkumar Iyer, Samir H Moussa, Rubén A Tommasi, Alita A Miller
Titrating Levels of TolC in E. coli: A Sensitive Approach to Quantifying Efflux. ACS infectious diseases 5 (1) (2018)
Ramkumar Iyer, Zhengqi Ye, Annette Ferrari, Leonard Duncan, M Angela Tanudra, Hong Tsao, Tiansheng Wang, Hong Gao, Christopher L Brummel, Alice L Erwin
Evaluating LC-MS/MS To Measure Accumulation of Compounds within Bacteria. ACS infectious diseases 4 (9) (2018)
Rubén A Tommasi, Ramkumar Iyer, Alita A Miller
Antibacterial Drug Discovery: Some Assembly Required. ACS infectious diseases 4 (5) (2018)
Ramkumar Iyer, Samir H Moussa, Thomas F Durand-Réville, Ruben Tommasi, Alita A Miller
Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin. ACS infectious diseases 4 (3) (2017)

Ramkumar Iyer.css-eqlu8i{font-size:small;padding-left:4px;}